Free Information Kit

Learn more about living with lupus and treatment with BENLYSTA

Already taking BENLYSTA?

Get ongoing support for your treatment journey.

Expand to watch videos from
real lupus patients taking BENLYSTA.

Financial Support Programs

Your doctor is your primary medical partner, but you can get additional support by calling BENLYSTA Gateway.

BENLYSTA® Gateway

BENLYSTA Gateway is staffed with experts who can:

  • answer questions about your insurance plan's coverage of BENLYSTA
  • help you understand your out-of-pocket cost for BENLYSTA
  • explain financial support programs that may help you afford BENLYSTA

Call BENLYSTA Gateway toll-free Monday through Friday, 8 AM to 8 PM Eastern Time, at 1-877-4-BENLYSTA (1-877-423-6597).

Choose What's Right for You

Start taking advantage of all we have to offer. No matter what kind of support you are looking for, work with your doctor to fill out the front of the BENLYSTA Gateway Enrollment Form. Then sign on the back and fax the form to us. One of our specialists will review it and contact you.

one

Ready to find out your insurance plan coverage for BENLYSTA?

Check the box “Benefits Verification” on the front of the form.

two

Want to find out if you're eligible for $0 co-pay?

Check the box “Co-Pay Program” on the front of the form. Eligible patients will have a $0 co-pay up to a total of $9,000 annually. Learn more about BENLYSTA Co-Pay Program here.

three

Are you uninsured and looking for assistance?

Check the appropriate box on the front of the form. Then fill out the Patient Assistance Program section on the back of the form. Subject to eligibility requirements, uninsured patients may be able to receive medication free of charge.

four

Want ongoing support from BENLYSTA?

Fill out the educational support section on the back of the form.

Toll-free number

BENLYSTA Gateway
1-877-4-BENLYSTA

(1-877-423-6597)
Monday through Friday, 8 AM to 8 PM Eastern Time

Real answers from
a real person

Call the BENLYSTA┬« Gateway toll-free Monday-Friday 8AM – 8PM EST at 1-877-4-BENLYSTA (1-877-423-6597)

What Is BENLYSTA?

BENLYSTA is a prescription medication used to treat adults with active systemic lupus erythematosus (SLE or lupus) who are receiving other lupus medicines.

It is not known if BENLYSTA is safe and effective in people with severe active lupus nephritis or severe active central nervous system lupus, and it has not been studied in combination with other biologics or intravenous cyclophosphamide. Use of BENLYSTA is not recommended in these situations.

Important Safety Information

The most important information to know about BENLYSTA:

BENLYSTA can cause serious side effects. Some of these side effects may cause death. It is not known if BENLYSTA causes these serious side effects.

Important Safety Information

The most important information to know about BENLYSTA:

BENLYSTA can cause serious side effects. Some of these side effects may cause death. It is not known if BENLYSTA causes these serious side effects.

Tell your healthcare professional right away if you have any of the symptoms listed below while receiving BENLYSTA

Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA.

Before receiving BENLYSTA also discuss with your healthcare professional if you:

Women of childbearing age should use adequate birth control measures while taking BENLYSTA and for at least four months after their final treatment with BENLYSTA.

Remember to tell your healthcare professional about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.

Possible side effects of BENLYSTA

The most common side effects of BENLYSTA include:

Tell your healthcare professional if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of BENLYSTA. For more information, ask your healthcare professional.

Other Important Information

In 2 of 3 studies, fewer blacks/African Americans who received BENLYSTA responded to treatment compared to blacks/African Americans who did not receive BENLYSTA. Therefore, caution should be used when considering treatment with BENLYSTA in blacks/African Americans. It is important to discuss with your healthcare professional whether BENLYSTA is right for you. A clinical trial is ongoing to study BENLYSTA specifically in blacks/African Americans with lupus.


For more information, call the BENLYSTA® Gateway at 1-877-4-BENLYSTA (1-877-423-6597)
Monday through Friday, 8 AM to 8 PM Eastern Time.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.